Assignee
SYMBERIX INC
US·1 granted patent·2 pending applications·1 citations·filing 2018–2024
Top patents by PatentIndex Score
3 records- 0173US12017994B2Compounds, compositions, and methods for selectively inhibiting β-glucuronidases and alleviating side effects associated with drug treatment induced diarrheaSYMBERIX INC·Filed 2018·Granted Jun 25, 2024·1 cites·12 claims
- 0267US2024417377A1COMPOUNDS, COMPOSITIONS, AND METHODS FOR SELECTIVELY INHIBITING ß-GLUCURONIDASES AND ALLEVIATING SIDE EFFECTS ASSOCIATED WITH DRUG TREATMENT INDUCED DIARRHEASYMBERIX INC·Filed 2024·Application pending·0 cites
- 0341US2022125778A1Compounds, compositions, and methods for selectively inhibiting beta-glucuronidases and alleviating side effects associated with drug treatment induced diarrheaSYMBERIX INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →